Injective Revenue to FDV Ratio Tops Major Blockchains: Can INJ Benefit?
Photo: Coinpedia
Injective leads the supplied 2026 YTD revenue to FDV comparison at 0.95, ahead of Solana and Arbitrum. Injective’s reported ratio is over eight times Ethereum's and more than ten times Sui’s and Avalanche’s. INJ Community BuyBack permanently removes tokens monthly, while future revenue growth depends on new initiatives and products. Injective is making a numbers driven pitch to crypto investors. Its revenue to fully dilution valuation (FDV) ratio now leads the major blockchain platforms shown in the year 2026 year to date comparison, putting INJ ahead of better known rivals on this particular metric. The catch?
Source: Coinpedia
